封面
市場調查報告書
商品編碼
1086304

多重診斷的全球市場:各產品類型,各用途,各終端用戶,各地區 - 規模,佔有率,展望,機會分析(2022年~2028年)

Multiplexed Diagnostic Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球多重診斷市場,由於自體免疫疾病的盛行率上升,大幅受到牽引。

本報告提供全球多重診斷市場相關調查分析,市場動態,趨勢分析,各地區分析,競爭情形等資訊。

目錄

第1章 調查目的、前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各產品
    • 市場明細:各用途
    • 市場明細:各終端用戶
    • 市場明細:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 法規情境
  • 產業趨勢
  • 合併和收購
  • 新產品的認證/銷售
  • 推銷及行銷舉措

第4章 全球多重診斷市場:各產品(2017年~2028年)

  • 簡介
  • 試劑、消耗品
  • 器具

第5章 全球多重診斷市場:各用途(2017年~2028年)

  • 簡介
  • 病的診斷
  • 分子診斷
  • 醫藥品開發

第6章 全球多重診斷市場:各終端用戶(2017年~2028年)

  • 簡介
  • 醫院
  • 臨床研究所
  • 學術機構、研究機關
  • 其他(製藥、診斷研究所)

第7章 全球多重診斷市場:各地區(2017年~2028年)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Luminex Corporation
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen NV
    • Abbott Laboratories
    • Siemens Healthineers
    • Agilent technologies
    • BioMerieux SA
    • F. Hoffmann-La Roche Ltd
  • 分析師的見解

第9章 Section

簡介目錄
Product Code: CMI983

The multiplexed diagnostic assay is used to identify multiple analytes in a single run cycle. Multiplex assay is used in the detection of defects such as mutation in functional biomolecules (DNA, mRNA, and protein) with the help of DNA microarray, multiplex PCR, and next-generation sequencing. In multiplexed diagnostic market, multiplexed diagnostic assay is executed in research & diagnostic laboratories, hospitals, and drug development. Moreover, this multiplexed diagnostic tool is also used in the diagnosis of various diseases, infections, drug screening, and biomarkers.

Market Dynamics

The multiplexed diagnostic market is gaining significant traction due to rising prevalence of autoimmune diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015 was 54 million in the U.S. adults (22.7%) and by 2040, it is expected to reach 78 million (26%) in the U.S. adults of age 18 years or above. The data represent high prevalence of autoimmune diseases, indicating the need of advance diagnostic measures, which is expected to boost growth of the multiplexed diagnostic market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global multiplexed diagnostic market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global multiplexed diagnostic market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, product type up-gradation, market expansion, and marketing tactics
  • The global multiplexed diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplexed diagnostic market

Detailed Segmentation:

  • Global Multiplexed Diagnostic Market, By Product Type:
  • Reagents & Consumables
  • Instruments
  • Global Multiplexed Diagnostic Market, By Application:
  • Disease Diagnostics
  • Molecular Diagnostics
  • Drug Development
  • Global Multiplexed Diagnostic Market, By End User:
  • Hospitals
  • Clinical Laboratories
  • Academic & Research Institutes
  • Others
  • Global Multiplexed Diagnostic Market, By Region:
  • North America

? By Product Type:

? Reagents & Consumables

? Instruments

? By Application:

? Disease Diagnostics

? Molecular Diagnostics

? Drug Development

? By End User:

? Hospitals

? Clinical Laboratories

? Academic & Research Institutes

? Others

? By Country:

? U.S.

? Canada

  • Latin America

? By Product Type:

? Reagents & Consumables

? Instruments

? By Application:

? Disease Diagnostics

? Molecular Diagnostics

? Drug Development

? By End User:

? Hospitals

? Clinical Laboratories

? Academic & Research Institutes

? Others

? By Country:

? Brazil

? Mexico

? Argentina

? Rest of Latin America

  • Europe

? By Product Type:

? Reagents & Consumables

? Instruments

? By Application:

? Disease Diagnostics

? Molecular Diagnostics

? Drug Development

? By End User:

? Hospitals

? Clinical Laboratories

? Academic & Research Institutes

? Others

? By Country:

? Germany

? U.K.

? France

? Italy

? Spain

? Russia

? Rest of Europe

  • Asia Pacific

? By Product Type:

? Reagents & Consumables

? Instruments

? By Application:

? Disease Diagnostics

? Molecular Diagnostics

? Drug Development

? By End User:

? Hospitals

? Clinical Laboratories

? Academic & Research Institutes

? Others

? By Country:

? China

? India

? Japan

? Australia

? South Korea

? ASEAN

? Rest of Asia Pacific

  • Middle East

? By Product Type:

? Reagents & Consumables

? Instruments

? By Application:

? Disease Diagnostics

? Molecular Diagnostics

? Drug Development

? By End User:

? Hospitals

? Clinical Laboratories

? Academic & Research Institutes

? Others

? By Country:

? GCC

? Israel

? Rest of Middle East

  • Africa

? By Product Type:

? Reagents & Consumables

? Instruments

? By Application:

? Disease Diagnostics

? Molecular Diagnostics

? Drug Development

? By End User:

? Hospitals

? Clinical Laboratories

? Academic & Research Institutes

? Others

? By Country/Region:

? South Africa

? Central Africa

? North Africa

  • Company Profiles
  • Luminex Corporation *

? Company Overview

? Material Portfolio

? Financial Performance

? Key Highlights

? Market Strategies

  • Thermo Fisher
  • Illumine Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Abbott Laboratories
  • Siemens Healthineers
  • Agilent technologies
  • BioMerieux SA
  • Hoffmann-La Roche Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Product
    • Market Snippet By Application
    • Market Snippet By End User
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Industry Trend
  • Merger and Acquisitions
  • New Product Approvals/Launch
  • Promotion and Marketing Initiatives

4. Global Multiplexed Diagnostic Market, By Product, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Reagents & Consumables
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

5. Global Multiplexed Diagnostic Market, By Application, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Disease Diagnostic
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Molecular Diagnostic
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

6. Global Multiplexed Diagnostic Market, By End User, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-O-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
  • Others (Pharmaceutical & Diagnostic Labs)
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

7. Global Multiplexed Diagnostic Market, By Regions, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Luminex Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Siemens Healthineers
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Agilent technologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • BioMerieux SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact